Panunzi S, Maltese S, Verrastro O, Labbate L, De Gaetano A, Pompili M, et al
Lemonaid scores reasonably well on transparency overall
Mitigation of risk by the higher intake of nutrient was considered significant if the estimate of was negative and statistically significant ( p 90th percentiles
10.1007/s13105-022-00939-9 59
Treatment with acmopatide showed a dose-dependent reduction in body weight, with decreases reaching up to 6.67%
To ensure that people do not take GLP-1 drugs without a medical prescription and to curb malpractices, the Drug Controller General of India, in collaboration with State Drug Controllers, took the following actions: On 10th March 2026, a comprehensive advisory was issued to all drug manufacturers to stop misleading advertisements and any promotion that could encourage people to use GLP-1 drugs without a prescription